Lyell Immunopharma Inc

LYELNASDAQ · USD
9.85USD0.00 (-2.67%)
1210

Lyell Immunopharma Inc (LYEL) Wheel Strategy

No qualifying wheel strategy setups were found for LYEL in the prior session.

Read more

Running a LYEL wheel strategy lets you generate consistent premium income on Lyell Immunopharma Inc while setting your own entry and exit prices on the underlying. Lyell Immunopharma Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own LYEL, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best LYEL wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on LYEL, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable LYEL wheel from a losing one.

Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications.

The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the LYEL wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your LYEL wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

No illustrative rows to display.

As of September 25, 2026

Run the Wheel on LYEL With Confidence

Find the best LYEL wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial